Annual Cash & Cash Equivalents:
$222.50M-$63.82M(-22.29%)Summary
- As of today, MIRM annual cash & cash equivalents is $222.50 million, with the most recent change of -$63.82 million (-22.29%) on December 31, 2024.
- During the last 3 years, MIRM annual cash & cash equivalents has risen by +$191.16 million (+609.96%).
- MIRM annual cash & cash equivalents is now -22.29% below its all-time high of $286.33 million, reached on December 31, 2023.
Performance
MIRM Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$375.55M+$71.00M(+23.31%)Summary
- As of today, MIRM quarterly cash & cash equivalents is $375.55 million, with the most recent change of +$71.00 million (+23.31%) on September 30, 2025.
- Over the past year, MIRM quarterly cash & cash equivalents has increased by +$91.10 million (+32.03%).
- MIRM quarterly cash & cash equivalents is now at all-time high.
Performance
MIRM Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MIRM Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -22.3% | +32.0% |
| 3Y3 Years | +610.0% | +102.6% |
| 5Y5 Years | +1758.8% | +180.8% |
MIRM Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -22.3% | +694.6% | at high | +184.3% |
| 5Y | 5-Year | -22.3% | +1758.8% | at high | +200.6% |
| All-Time | All-Time | -22.3% | +1758.8% | at high | +658.8% |
MIRM Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $375.55M(+23.3%) |
| Jun 2025 | - | $304.55M(+9.7%) |
| Mar 2025 | - | $277.67M(-0.9%) |
| Dec 2024 | $222.50M(-22.3%) | $280.31M(-1.5%) |
| Sep 2024 | - | $284.44M(+2.2%) |
| Jun 2024 | - | $278.37M(-8.1%) |
| Mar 2024 | - | $302.84M(+5.8%) |
| Dec 2023 | $286.33M(+922.5%) | $286.33M(-6.4%) |
| Sep 2023 | - | $306.03M(-7.3%) |
| Jun 2023 | - | $329.95M(+149.8%) |
| Mar 2023 | - | $132.07M(-12.9%) |
| Dec 2022 | $28.00M | $151.72M(-18.1%) |
| Sep 2022 | - | $185.35M(+48.3%) |
| Jun 2022 | - | $124.95M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $139.91M(-10.6%) |
| Dec 2021 | $31.34M(-77.9%) | $156.54M(-17.6%) |
| Sep 2021 | - | $190.03M(-15.1%) |
| Jun 2021 | - | $223.85M(+5.0%) |
| Mar 2021 | - | $213.11M(-8.1%) |
| Dec 2020 | $142.09M(+1087.0%) | $231.82M(+73.3%) |
| Sep 2020 | - | $133.75M(-10.4%) |
| Jun 2020 | - | $149.34M(-6.4%) |
| Mar 2020 | - | $159.53M(+36.7%) |
| Dec 2019 | $11.97M(-77.0%) | $116.66M(-7.6%) |
| Sep 2019 | - | $126.26M(+50.0%) |
| Jun 2019 | - | $84.19M(+70.1%) |
| Mar 2019 | - | $49.49M |
| Dec 2018 | $51.96M | - |
FAQ
- What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MIRM is $222.50M
What is the all-time high annual cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $286.33M
What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MIRM annual cash & cash equivalents has changed by -$63.82M (-22.29%)
What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MIRM is $375.55M
What is the all-time high quarterly cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $375.55M
What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MIRM quarterly cash & cash equivalents has changed by +$91.10M (+32.03%)